• BioLineRx Reports Third Quarter 2024 Financial Results and Provides Update on Transformation to Drive Shareholder Value Seeking Alpha Sun, 04 May 2025 12:00:02 GMT
• stocknews.com begins coverage on biolinerx (nasdaq:blrx) Defense World Fri, 02 May 2025 06:10:29 GMT
• biolinerx announces pricing of $15.4 million underwritten public offering of its american depositary shares and warrants | libero ... Libero Quotidiano Fri, 25 Apr 2025 09:00:53 GMT
• biolinerx announces closing of $15.4 million underwritten public offering of its american depositary shares and warrants | libero ... Libero Quotidiano Mon, 21 Apr 2025 15:40:59 GMT
• BioLineRx (NASDAQ:BLRX) Earns Hold Rating from Jones Trading Defense World Fri, 04 Apr 2025 07:00:00 GMT
• FY2025 EPS Estimates for BioLineRx Boosted by HC Wainwright Defense World Fri, 04 Apr 2025 07:00:00 GMT
• Research Analysts Issue Forecasts for BioLineRx Q1 Earnings Defense World Thu, 03 Apr 2025 07:00:00 GMT
• biolinerx stock rating cut to hold at jones trading by investing.com Investing.com Australia Wed, 02 Apr 2025 09:44:48 GMT
• BioLineRx Ltd. (NASDAQ:BLRX) Q4 2024 Earnings Call Transcript Insider Monkey Tue, 01 Apr 2025 07:00:00 GMT
• BLRX stock touches 52-week low at $2.85 amid sharp annual decline Investing.com Tue, 01 Apr 2025 07:00:00 GMT
• biolinerx (nasdaq:blrx) price target raised to $26.00 at hc wainwright Defense World Tue, 01 Apr 2025 07:00:00 GMT
• biolinerx ltd. reports 2024 financial results and strategic progress TipRanks Tue, 01 Apr 2025 04:56:31 GMT
• biolinerx price target adjusted to $26 at h.c. wainwright after reverse split TipRanks Mon, 31 Mar 2025 19:33:13 GMT
• BioLineRx Reports 2024 Financial Results and Provides Corporate Update PR Newswire Mon, 31 Mar 2025 07:00:00 GMT
• BioLineRx Reports Strong 2024 Financial Results and Strategic Advancements TipRanks Mon, 31 Mar 2025 07:00:00 GMT
• BioLineRx to Report 2024 Annual Results on March 31, 2025 PR Newswire Mon, 31 Mar 2025 07:00:00 GMT
• BioLineRx Ltd. Reports 2024 Financial Results and Strategic Progress TipRanks Mon, 31 Mar 2025 07:00:00 GMT
• Clinical-Stage Biotech BioLineRx Sets Date for 2024 Annual Results: CEO Briefing Announced Stock Titan Mon, 24 Mar 2025 07:00:00 GMT
• biolinerx to report 2024 annual results on march 31, 2025 Yahoo Finance Mon, 24 Mar 2025 07:00:00 GMT
• biolinerx (nasdaq:blrx) stock rating lowered by stocknews.com The AM Reporter Thu, 20 Mar 2025 07:00:00 GMT
• biolinerx (nasdaq:blrx) downgraded by stocknews.com to “sell” Defense World Wed, 19 Mar 2025 07:00:00 GMT
• biolinerx (blrx) projected to post earnings on tuesday Defense World Tue, 18 Mar 2025 06:00:06 GMT
• biolinerx ltd. (nasdaq:blrx) sees significant increase in short interest Defense World Sun, 02 Mar 2025 08:00:00 GMT
• biolinerx to report second quarter 2024 results on august 15, 2024 Marketscreener.com Thu, 20 Feb 2025 03:30:09 GMT
• stocknews.com initiates coverage on biolinerx (nasdaq:blrx) Defense World Tue, 04 Feb 2025 08:03:50 GMT
• biolinerx stock hits 52-week low at $3.24 amid sharp decline Investing.com Australia Sat, 01 Feb 2025 08:00:00 GMT
• BioLineRx stock hits 52-week low at $3.24 amid sharp decline Investing.com Fri, 31 Jan 2025 08:00:00 GMT
• stocknews.com initiates coverage on biolinerx (nasdaq:blrx) Defense World Mon, 27 Jan 2025 08:00:00 GMT
• biolinerx issues letter to shareholders – company announcement Financial Times Tue, 21 Jan 2025 12:00:00 GMT
• BioLineRx announces strategic shift with licensing deals Investing.com Tue, 21 Jan 2025 08:00:00 GMT
• biolinerx secures $25m upfront in major licensing deals, extends cash runway to 2026 Stock Titan Tue, 21 Jan 2025 08:00:00 GMT
• biolinerx outlines strategic vision and financial outlook after key licensing deals TipRanks Tue, 21 Jan 2025 08:00:00 GMT
• biolinerx (nasdaq:blrx) earns hold rating from analysts at stocknews.com Defense World Sun, 19 Jan 2025 08:00:00 GMT
• biolinerx (nasdaq:blrx) shares set to reverse split on thursday, january 30th Defense World Sat, 18 Jan 2025 08:00:00 GMT
• BioLineRx Announces 1:40 ADS Ratio Change, Confirms $29.5M Cash Runway Through 2026 Stock Titan Fri, 17 Jan 2025 08:00:00 GMT
• BioLineRx Announces Change to Ratio of American Depositary Shares to Ordinary Shares PR Newswire Fri, 17 Jan 2025 08:00:00 GMT
• biolinerx stock touches 52-week low at $0.14 amid downturn Investing.com Mon, 13 Jan 2025 08:00:00 GMT
• biolinerx (nasdaq:blrx) coverage initiated by analysts at stocknews.com Defense World Sat, 11 Jan 2025 07:18:41 GMT
• biolinerx announces $10 million registered direct offering The Malaysian Reserve Tue, 07 Jan 2025 08:38:15 GMT
• BiolineRx Announces Major Direct Offering to Bolster Operations TipRanks Tue, 07 Jan 2025 08:00:00 GMT
• biolinerx announces $10m registered direct offering; shares tumble MSN Tue, 07 Jan 2025 08:00:00 GMT
• biolinerx stock plunges to 52-week low of $0.19 amid market challenges Investing.com Australia Tue, 07 Jan 2025 08:00:00 GMT
• biolinerx announces $10m registered direct offering; shares tumble MSN Mon, 06 Jan 2025 14:48:47 GMT
• BioLineRx Raises $10M in Direct Offering at $0.20 Per ADS with Matching Warrants Stock Titan Mon, 06 Jan 2025 08:00:00 GMT
• BioLineRx Announces $10 Million Registered Direct Offering PR Newswire Mon, 06 Jan 2025 08:00:00 GMT
• BioLineRx Announces $10 Million Direct Offering to Fuel Growth TipRanks Mon, 06 Jan 2025 08:00:00 GMT
• biolinerx stock plunges to 52-week low of $0.19 amid market challenges Investing.com Mon, 06 Jan 2025 08:00:00 GMT
• stocknews.com begins coverage on biolinerx (nasdaq:blrx) Defense World Thu, 26 Dec 2024 08:00:00 GMT
• biolinerx stock hits 52-week low at $0.21 amid market challenges Investing.com Mon, 16 Dec 2024 08:00:00 GMT
• biolinerx to report third quarter 2024 results on november 25, 2024 Longview News-Journal Sun, 08 Dec 2024 01:12:17 GMT
• biolinerx to report third quarter 2024 results on november 25, 2024 Kilgore News Herald Sat, 07 Dec 2024 18:17:27 GMT
• biolinerx stock plunges to 52-week low, hits $0.25 by investing.com Investing.com Canada Sat, 07 Dec 2024 09:50:23 GMT
• biolinerx stock jumps 14% on st. jude clinical trial for mitoxafortide MSN Sat, 30 Nov 2024 08:01:00 GMT
• biolinerx ltd. (nasdaq:blrx) q3 2024 earnings call transcript Insider Monkey Tue, 26 Nov 2024 08:00:00 GMT
• biolinerx stock target cut, retains buy on q3 financial results Investing.com Tue, 26 Nov 2024 08:00:00 GMT
• biolinerx reports third quarter 2024 financial results and provides update on transformation to drive shareholder value PR Newswire Mon, 25 Nov 2024 08:00:00 GMT
• biolinerx price target lowered to $9 from $21 at h.c. wainwright Nasdaq Mon, 25 Nov 2024 08:00:00 GMT
• biolinerx inks $97m licensing deal, secures $9m investment amid q3 results StockTitan Mon, 25 Nov 2024 08:00:00 GMT
• biolinerx to report third quarter 2024 results on november 25, 2024 PR Newswire Mon, 25 Nov 2024 08:00:00 GMT
• biolinerx earnings beat by $0.04, revenue topped estimates Investing.com Nigeria Mon, 25 Nov 2024 08:00:00 GMT
• earnings call: biolinerx announces q3 results and strategic shifts Investing.com Mon, 25 Nov 2024 08:00:00 GMT
• biolinerx to report third quarter 2024 results on november 25, 2 GuruFocus.com Sat, 23 Nov 2024 22:27:27 GMT
• BioLineRx, Ayrmid enter license agreement for motixafortide through Gamida Cell Yahoo Finance Fri, 22 Nov 2024 08:00:00 GMT
• biolinerx stock hits 52-week low at $0.38 amid market challenges Investing.com Australia Fri, 22 Nov 2024 08:00:00 GMT
• biolinerx announces uspto allowance of new composition of matter patent on motixafortide GuruFocus.com Fri, 22 Nov 2024 00:53:27 GMT
• biolinerx, ayrmid enter license agreement for motixafortide through gamida cell TipRanks Thu, 21 Nov 2024 12:38:54 GMT
• biolinerx ltd. and biolinerx usa, inc announces stepdown of holly may as president Marketscreener.com Thu, 21 Nov 2024 11:50:00 GMT
• BioLineRx and Ayrmid Ltd. Enter into Exclusive License Agreement to Commercialize APHEXDA® (motixafortide) through Gamida Cell Ltd... PR Newswire Thu, 21 Nov 2024 08:00:00 GMT
• biolinerx stock sinks on share purchase deal (blrx:nasdaq) Seeking Alpha Thu, 21 Nov 2024 08:00:00 GMT
• biolinerx stock hits 52-week low at $0.38 amid market challenges Investing.com Thu, 21 Nov 2024 08:00:00 GMT
• biolinerx lands $10m deal with ayrmid for aphexda, plus $87m in milestone potential StockTitan Thu, 21 Nov 2024 08:00:00 GMT
• amended: biolinerx inks license agreement with ayrmid to commercialize aphexda Nasdaq Thu, 21 Nov 2024 08:00:00 GMT
• BioLineRx to Report Third Quarter 2024 Results on November 25, 2024 Yahoo Finance Wed, 20 Nov 2024 08:00:00 GMT
• biolinerx to report q3 2024 financial results on november 25 StockTitan Wed, 20 Nov 2024 08:00:00 GMT
• more stem cells for sickle cell gene therapy readied with motixafortide Sickle Cell Disease News Thu, 14 Nov 2024 08:00:00 GMT
• hc wainwright reiterates buy rating for biolinerx (nasdaq:blrx) Defense World Sun, 10 Nov 2024 07:09:22 GMT
• BioLineRx Announces Oral Presentation on Data from Phase 1 Clinical Trial Evaluating Motixafortide for CD34+ Hematopoietic Stem Ce... PR Newswire Tue, 05 Nov 2024 08:00:00 GMT
• biolinerx’s motixafortide shows promise in sickle cell trials TipRanks Tue, 05 Nov 2024 08:00:00 GMT
• biolinerx's motixafortide shows 3.2x better stem cell mobilization in breakthrough scd trial | blrx stock news StockTitan Tue, 05 Nov 2024 08:00:00 GMT
• biolinerx stock hits 52-week low at $0.39 amid market challenges Investing.com Thu, 24 Oct 2024 07:00:00 GMT
• biolinerx receives uspto allowance of new composition of matter patent on motixafortide MSN Mon, 21 Oct 2024 03:33:13 GMT
• biolinerx initiates phase 1b/2 trial for bl-8040 in gastric cancer under immunotherapy collaboration Reuters Fri, 18 Oct 2024 07:00:00 GMT
• biolinerx stock hits 52-week low at $0.43 amid market challenges Investing.com India Thu, 17 Oct 2024 05:15:20 GMT
• biolinerx to present at 2013 annual jmp securities healthcare conference in new york AOL Wed, 16 Oct 2024 13:32:04 GMT
• biolinerx ltd. announces uspto allowance of new composition of matter patent on motixafortide Marketscreener.com Wed, 16 Oct 2024 11:09:00 GMT
• biolinerx stock hits 52-week low at $0.43 amid market challenges Investing.com Nigeria Wed, 16 Oct 2024 10:18:29 GMT
• biolinerx announces uspto allowance of new composition of matter patent on motixafortide Yahoo Finance Wed, 16 Oct 2024 07:00:00 GMT
• biolinerx secures us patent for cancer drug motixafortide Investing.com Wed, 16 Oct 2024 07:00:00 GMT
• biolinerx receives notification of allowance from uspto for motixafortide TipRanks Wed, 16 Oct 2024 07:00:00 GMT
• biolinerx stock hits 52-week low at $0.43 amid market challenges Investing.com Tue, 15 Oct 2024 07:00:00 GMT
• biolinerx (nasdaq:blrx) research coverage started at stocknews.com Defense World Tue, 15 Oct 2024 06:29:20 GMT
• biolinerx stock hits 52-week low at $0.5 amid market challenges Investing.com Thu, 03 Oct 2024 00:30:41 GMT
• biolinerx stock hits 52-week low at $0.5 amid market challenges Investing.com Wed, 02 Oct 2024 07:00:00 GMT
• biolinerx announces initiation of phase 1b/2 trial for bl-8040 in aml under immunotherapy collaboration Reuters Thu, 26 Sep 2024 07:00:00 GMT
• biolife solutions, inc. (nasdaq:blfs) cro garrie richardson sells 3,070 shares Defense World Wed, 18 Sep 2024 22:39:10 GMT
• bionexus gene lab corp. (nasdaq:bglc) short interest update Defense World Wed, 18 Sep 2024 20:57:56 GMT
• biolinerxl launches digital resource for mm patients ‘mobilization matters’ TipRanks Tue, 17 Sep 2024 17:45:58 GMT
• bionexus gene lab corp (bglc) stock: a year of market fluctuations The InvestChronicle Tue, 17 Sep 2024 17:11:34 GMT
• BioLineRx Launches 'Mobilization Matters': A Digital Resource for People with Multiple Myeloma Preparing for Stem Cell Collection PR Newswire Tue, 17 Sep 2024 07:00:00 GMT
• reviewing biolargo (nasdaq:blgo) and loop industries (nasdaq:loop) Defense World Tue, 17 Sep 2024 05:44:08 GMT
• biolinerx stock jumps 14% on st. jude clinical trial for mitoxafortide MSN Mon, 16 Sep 2024 18:49:06 GMT
• there is no way bionexus gene lab corp (bglc) can keep these numbers up SETE News Mon, 16 Sep 2024 11:11:36 GMT
• biolinerx ltd receives investment bank analyst rating update by investing.com Investing.com UK Tue, 03 Sep 2024 07:00:00 GMT
• seborrheic keratosis treatment market report 2024-2030, GlobeNewswire Thu, 29 Aug 2024 04:16:23 GMT
• Seborrheic Keratosis Treatment Market Report 2024-2030, GlobeNewswire Wed, 28 Aug 2024 07:00:00 GMT
• equities analysts issue forecasts for biolinerx ltd.'s fy2024 earnings (nasdaq:blrx) MarketBeat Thu, 22 Aug 2024 12:12:21 GMT
• fy2024 earnings forecast for biolinerx ltd. issued by zacks small cap (nasdaq:blrx) MarketBeat Thu, 22 Aug 2024 07:00:00 GMT
• earnings call: biolinerx beats q2 goals with strong aphexda demand Investing.com India Fri, 16 Aug 2024 07:00:00 GMT
• biolinerx ltd. (nasdaq:blrx) q2 2024 earnings call transcript Insider Monkey Fri, 16 Aug 2024 07:00:00 GMT
• biolinerx to report second quarter 2024 results on august 15, 2024 PR Newswire Thu, 15 Aug 2024 07:00:00 GMT
• biolinerx reports second quarter 2024 financial results and recent corporate and portfolio updates Yahoo Finance Thu, 15 Aug 2024 07:00:00 GMT
• biolinerx ltd. (nasdaq:blrx) sees large growth in short interest MarketBeat Tue, 13 Aug 2024 19:42:12 GMT
• biolinerx ltd. (nasdaq:blrx) sees significant growth in short interest MarketBeat Tue, 13 Aug 2024 19:42:12 GMT
• biolinerx ltd. (nasdaq:blrx) sees large increase in short interest Defense World Tue, 13 Aug 2024 08:37:45 GMT
• biolinerx (blrx) set to announce quarterly earnings on thursday Defense World Tue, 13 Aug 2024 07:36:43 GMT
• biolinerx to report second quarter 2024 results on august 15, 2024 PR Newswire Thu, 08 Aug 2024 07:00:00 GMT
• cxcr4 antagonists industry to witness massive growth (2024-2034) |sanofi, biolinerx, x4 pharmaceuticals, eli lilly, roch – la func... La Funcion mx Wed, 31 Jul 2024 16:38:41 GMT
• biolinerx ltd. (nasdaq:blrx) short interest down 63.1% in july Defense World Fri, 26 Jul 2024 10:59:22 GMT
• short interest in biolinerx ltd. (nasdaq:blrx) decreases by 63.1% MarketBeat Thu, 25 Jul 2024 18:30:05 GMT
• biolinerx ltd. (nasdaq:blrx) sees significant decrease in short interest MarketBeat Thu, 25 Jul 2024 07:00:00 GMT
• short interest in biolinerx ltd. (nasdaq:blrx) expands by 52.9% Defense World Mon, 15 Jul 2024 10:57:07 GMT
• biolinerx ltd. (nasdaq:blrx) short interest up 52.9% in june MarketBeat Sat, 13 Jul 2024 15:09:43 GMT
• biolinerx ltd. (nasdaq:blrx) sees significant increase in short interest MarketBeat Sat, 13 Jul 2024 07:00:00 GMT
• [newest] liver failure therapeutics market 2031 | alfact innovation, biolinerx ltd, cell2b advanced therapeutics sa ... Economica Sun, 07 Jul 2024 06:01:24 GMT
• biolinerx begins part 2 of phase i/iia study on solid tumors Yahoo New Zealand News Thu, 27 Jun 2024 05:33:00 GMT
• blrx investors have opportunity to lead biolinerx ltd. securities fraud lawsuit Marketscreener.com Sat, 22 Jun 2024 22:23:11 GMT
• rosen, skilled investor counsel, encourages biolinerx ltd. investors with losses to secure counsel before ... Marketscreener.com Sat, 22 Jun 2024 18:46:35 GMT
• blrx investor notice: rosen, leading investor counsel, encourages biolinerx ltd. investors to secure ... Marketscreener.com Sat, 22 Jun 2024 10:42:30 GMT
• short interest in biolinerx ltd. (nasdaq:blrx) grows by 62.6% Defense World Sun, 16 Jun 2024 06:22:03 GMT
• reviewing biolinerx (nasdaq:blrx) & entrada therapeutics (nasdaq:trda) Defense World Sat, 15 Jun 2024 07:00:00 GMT
• biolinerx ltd. (nasdaq:blrx) sees large increase in short interest MarketBeat Fri, 14 Jun 2024 21:03:02 GMT
• blrx - biolinerx reports second quarter 2011 financial results br.ADVFN.com Fri, 14 Jun 2024 13:55:33 GMT
• equities analysts set expectations for biolinerx ltd.'s q2 2024 earnings (nasdaq:blrx) MarketBeat Thu, 13 Jun 2024 11:59:15 GMT
• biolinerx ltd. to post q2 2024 earnings of ($0.01) per share, zacks small cap forecasts (nasdaq:blrx) MarketBeat Thu, 13 Jun 2024 11:59:15 GMT
• biolinerx ltd. (nasdaq:blrx) to post q2 2024 earnings of ($0.01) per share, zacks small cap forecasts Defense World Thu, 13 Jun 2024 11:01:27 GMT
• biolinerx ltd. (nasdaq:blrx) forecasted to earn fy2026 earnings of ($0.02) per share Defense World Wed, 12 Jun 2024 11:26:09 GMT
• biolinerx stock plunges to 52-week low, hits $0.25 by investing.com Investing.com Nigeria Wed, 12 Jun 2024 07:00:00 GMT
• biolinerx ltd. (nasdaq:blrx) expected to post fy2026 earnings of ($0.02) per share MarketBeat Wed, 12 Jun 2024 07:00:00 GMT
• bioline rx (blrx) catches eye: stock adds 5.2% in session Yahoo Movies UK Tue, 11 Jun 2024 20:55:50 GMT
• biolinerx doses first subject in phase ii pancreatic cancer trial MSN Fri, 07 Jun 2024 08:48:52 GMT
• study to test motixafortide stem cell mobilization for scd gene therapies Sickle Cell Disease News Thu, 06 Jun 2024 07:00:00 GMT
• millionaire makers: 7 stocks you can buy for $2 that can 10x by 2025 InvestorPlace Wed, 05 Jun 2024 07:00:00 GMT
• biolinerx (nasdaq:blrx) upgraded by stocknews.com to hold Defense World Tue, 04 Jun 2024 20:09:54 GMT
• hc wainwright weighs in on biolinerx ltd.'s q2 2024 earnings (nasdaq:blrx) Defense World Sat, 01 Jun 2024 07:00:00 GMT
• analysts issue forecasts for biolinerx ltd.'s q2 2024 earnings (nasdaq:blrx) MarketBeat Fri, 31 May 2024 18:20:06 GMT
• analysts offer predictions for biolinerx ltd.'s q2 2024 earnings (nasdaq:blrx) MarketBeat Fri, 31 May 2024 07:00:00 GMT
• biolinerx trials new sickle cell gene therapy - tipranks.com TipRanks Thu, 30 May 2024 12:06:19 GMT
• biolinerx's (blrx) buy rating reaffirmed at hc wainwright Defense World Thu, 30 May 2024 08:19:12 GMT
• BioLineRx Announces Clinical Trial Agreement with St. Jude Children's Research Hospital, Inc. to Evaluate Motixafortide for CD34+ ... PR Newswire Thu, 30 May 2024 07:00:00 GMT
• biolinerx stock jumps 14% on st. jude clinical trial for mitoxafortide (nasdaq:blrx) Seeking Alpha Thu, 30 May 2024 07:00:00 GMT
• israeli biopharma firm leading us trial of potential scd drug NoCamels - Israeli Innovation News Thu, 30 May 2024 07:00:00 GMT
• biolinerx (nasdaq:blrx) issues quarterly earnings results, beats estimates by $0.28 eps Defense World Thu, 30 May 2024 07:00:00 GMT
• short interest in biolinerx ltd. (nasdaq:blrx) decreases by 46.6% MarketBeat Thu, 30 May 2024 03:16:32 GMT
• earnings call: biolinerx q1 2024 results show steady progress Investing.com South Africa Thu, 30 May 2024 01:20:05 GMT
• biolinerx's (blrx) "buy" rating reaffirmed at hc wainwright MarketBeat Wed, 29 May 2024 16:18:32 GMT
• biolinerx (nasdaq:blrx) announces quarterly earnings results MarketBeat Wed, 29 May 2024 16:18:32 GMT
• biolinerx (nasdaq:blrx) given "buy" rating at hc wainwright MarketBeat Wed, 29 May 2024 16:18:32 GMT
• earnings call: biolinerx q1 2024 results show steady progress Investing.com Wed, 29 May 2024 07:00:00 GMT
• talen energy prepares for nasdaq global select market listing by investing.com Investing.com Wed, 29 May 2024 07:00:00 GMT
• us prosecutors meeting with boeing, crash victims as criminal charging decision looms, sources say by reuters Investing.com Wed, 29 May 2024 07:00:00 GMT
• biolinerx ltd. (nasdaq:blrx) q1 2024 earnings call transcript Insider Monkey Wed, 29 May 2024 07:00:00 GMT
• short interest in biolinerx ltd. (nasdaq:blrx) decreases by 46.6% MarketBeat Wed, 29 May 2024 07:00:00 GMT
• biolinerx reports first quarter 2024 financial results and recent corporate and portfolio updates The Malaysian Reserve Wed, 29 May 2024 00:55:06 GMT
• biolinerx reports first quarter 2024 financial results and recent corporate and portfolio updates Yahoo Finance Tue, 28 May 2024 07:00:00 GMT
• biolinerx ltd. (blrx) q1 2024 earnings call transcript Seeking Alpha Tue, 28 May 2024 07:00:00 GMT
• biolinerx to report first quarter 2024 results on may 28, 2024 Investing.com India Tue, 28 May 2024 07:00:00 GMT
• biolinerx reports q1 eps 0c vs. (1c) last year - tipranks.com TipRanks Tue, 28 May 2024 07:00:00 GMT
• biolinerx to present new data from chemo4metpanc phase 2 at asco - tipranks.com TipRanks Sat, 25 May 2024 11:12:22 GMT
• biolinerx reports positive pancreatic cancer trial results Investing.com India Fri, 24 May 2024 07:00:00 GMT
• biolinerx to report first quarter 2024 results on may 28, 2024 Yahoo Finance Wed, 22 May 2024 07:00:00 GMT
• biolinerx (blrx) to report q2 earnings: what's in the cards? Yahoo Sport Australia Mon, 20 May 2024 23:38:45 GMT
• biolinerx receives nasdaq minimum bid price notification - tipranks.com TipRanks Sat, 18 May 2024 21:15:21 GMT
• biolinerx faces nasdaq minimum bid price noncompliance by investing.com Investing.com Australia Sat, 18 May 2024 00:00:24 GMT
• biolinerx announces receipt of nasdaq minimum bid price notification Yahoo Finance Fri, 17 May 2024 07:00:00 GMT
• biolinerx faces nasdaq minimum bid price noncompliance by investing.com Investing.com Fri, 17 May 2024 07:00:00 GMT
• short interest in biolinerx ltd. (nasdaq:blrx) declines by 47.6% MarketBeat Sat, 11 May 2024 07:00:00 GMT
• biolinerx reveals cost-saving stem cell mobilization data - tipranks.com TipRanks Mon, 06 May 2024 15:06:26 GMT
• biolinerx announces poster presentation on economic model data for aphexda® (motixafortide) as part of cd34+ hematopoietic stem ce... Yahoo Finance Mon, 06 May 2024 07:00:00 GMT
• metastatic pancreatic cancer treatment market business insights, key trend analysis | lilly, merck, celgene, biolinerx Amoré Tue, 30 Apr 2024 13:40:37 GMT
• pancreatic cancer metastasis treatment market size analysis| lilly, merck, celgene, biolinerx - motions online Motions Online Mon, 29 Apr 2024 21:32:18 GMT
• biolinerx (nasdaq:blrx) raised to “sell” at stocknews.com Defense World Tue, 23 Apr 2024 10:08:53 GMT
• biolinerx (nasdaq:blrx) upgraded by stocknews.com to "sell" MarketBeat Tue, 23 Apr 2024 09:34:25 GMT
• biolinerx's (blrx) “buy” rating reiterated at hc wainwright Defense World Fri, 19 Apr 2024 05:59:16 GMT
BioLineRx Ltd(NASDAQ:BLRX) 
BioLineRx Ltd., a clinical-stage biopharmaceutical development company, focuses on oncology. Its development pipeline consists of clinical-stage therapeutic candidates, which include BL-8040, a peptide for the treatment of solid tumors, hematological malignancies, and stem cell mobilization; AGI-134...
Website: http://www.biolinerx.com
Founded: 2003
Full Time Employees: 42
Sector: Healthcare
Industry: Biotechnology